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Asthma in childhood: a complex, heterogeneous 
disease
Asthma in childhood is a heterogeneous disease with different pheno-
types and variable clinical manifestations, which depend on the age, 
gender, genetic background, and environmental influences of the 
patients. Several longitudinal studies have been conducted to classify 
the phenotypes of childhood asthma, on the basis of the symptoms, 
triggers of wheezing illness, or pathophysiological features of the disease. 
These studies have provided us with important information about the 
different wheezing phenotypes in young children and about potential 
mechanisms and risk factors for the development of chronic asthma. The 
goal of these studies was to provide a better insight into the causes and 
natural course of childhood asthma. It is well-known that complicated 
interactions between genes and environmental factors contribute to the 
development of asthma. Because childhood is a period of rapid growth 
in both the lungs and the immune system, developmental factors should 
be considered in the pathogenesis of childhood asthma. The pulmonary 
system continues to grow and develop until linear growth is completed. 
Longitudinal studies have reported significant age-related immune 
development during postnatal early life. These observations suggest that 
the phenotypes of childhood asthma vary among children and also in 
an individual child over time. Improved classification of heterogeneous 
conditions of the disease will help determine novel strategies for primary 
and secondary prevention and for the development of individualized 
treatment for childhood asthma. 
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associated with lower airway obstruction during childhood
2). All 
these factors complicate our understanding of the pathogenesis and 
natural course of childhood asthma.
It is well-known that a complex interplay between genetic 
predisposition and environmental influences contributes to the 
development of asthma. However, in the pathogenesis of childhood 
Introduction
Asthma in children is a heterogeneous disease comprising different 
phenotypes
1). Wheezing, a non-specific sign of airflow restriction in 
narrowed airways, is a major clinical expression of childhood asthma. 
Furthermore, many different conditions have been reported to be 2      HL Chung • Asthma in childhood: a complex, heterogeneous disease
asthma, developmental factors should be considered, including 
factors related both to the lungs and immune system
3). Childhood is 
a period of rapid growth and pronounced changes in the pulmonary 
and immune systems. Longitudinal studies on the development of 
the immune system have shown a significant age-related development 
during postnatal early life difference during early life
4-6). Our 
previous study showed significant developmental changes in cytokine 
responses during the early years of life
7). We also observed significant 
age-related differences in interferon (IFN)-γ  and interleukin (IL)-
13 responses in children with acute respiratory syncytial virus (RSV) 
bronchiolitis
7). 
Lung development is a process that begins in the 4th week of 
gestation and continues for a significant period after birth
8, 9). Alveolar 
multiplication, the final stage of lung differentiation, begins at 
term and continues for the first 2-3 years of life
8). The lungs grows 
throughout childhood, and the development of lung function 
roughly parallels the increase in height, which continues until 
adolescence, when the linear growth is completed
9, 10). 
Collectively, these observations suggest that the phenotypes of 
childhood asthma vary among children depending upon their age, 
gender, genetic backgrounds, and environmental exposure, and vary 
within an individual child over time. 
Clinical findings in major epidemiologic studies
 Several major epidemiologic studies have provided information 
about the clinical course of childhood asthma as children age. The 
first study was the Melbourne Asthma Study that started in 1967. 
Children with asthma and a set of normal individuals were enrolled 
at age 7 and followed at age 10, 14, 21, 28, 35, and 42
11-13). This cohort 
study showed that asthma symptoms improved by adolescence, but 
many relapsed as they aged into adulthood. Children with infrequent 
wheezing usually outgrew their asthma by early adolescence, while 
those with more severe symptoms continued to have persistent 
asthma. This same cohort demonstrated that those children with 
“severe asthma” presented decreased lung function, which did not 
improve with age but did not decrease further when they became 
adults. The study suggests that some asthmatic children are either 
born with reduced lung function or they lose lung function during 
the first few years, before 7 years of age, after which no further loss 
occurs. Sears et al. evaluated a birth cohort that started in 1972 in 
New Zealand and followed up on 7 occasions from age 9 to 26
14). At 
26 years of age, of the 613 subjects who had complete data, 26.9% 
were still wheezing, 14.5% had persistent wheezing from onset, and 
12.4% presented a remission followed by relapse. The risk factors 
for persistent or relapsing wheezing were greater bronchial hyper-
responsiveness, sensitization to house dust mites, female gender, 
exposure to tobacco smoke, and early start of wheezing. These 
findings strongly suggest that the interaction, during early life, 
between environmental factors and asthma-specific genetic factors is 
crucial in the development of later asthma in the wheezy infants. 
The Childhood Asthma Management Program (CAMP) is the 
largest and longest clinical trial in children with mild to moderate 
asthma diagnosed by the current asthma guidelines
15). The CAMP 
study has now evolved into an epidemiological study of the natural 
course of childhood asthma. The study has shown that longer 
duration of asthma in these patients was significantly correlated with 
a greater degree of airway hyper-responsiveness and significant effects 
on lung growth, which is consistent with the previous longitudinal 
studies. However, the percentage of CAMP participants with an 
abnormally low FEV1/FVC ratio increased with age, signaling 
progressive effects of asthma on lung function in adolescence, which 
differs from findings in the previous studies. 
Longitudinal epidemiological studies have shown that early 
childhood asthma generally improves during adolescence and young 
adulthood. They also indicate that, the more severe asthma is in 
childhood, the less likely it is that remission will occur. Decreased 
lung function occurs early and does not change further with aging; 
however, the CAMP cohort showed a progressive effect of persistent 
asthma on lung function during adolescence. These studies suggest 
that early diagnosis and intervention are needed to reduce adverse 
outcomes of childhood asthma.
Different asthma phenotypes in childhood
It is well known that there are different patterns of wheezing in 
young children, probably with some superposition between them. 
The classic epidemiological phenotypes were described in the Tucson 
study, based on the time of onset and persistence of symptoms
1,16). 
These findings were amplified in the Avon Longitudinal Study of 
Parents and Children
17). 
The Tucson study proposed 3 classical phenotypes of childhood 
wheezing or asthma: transient early wheezers, non-atopic wheezers, 
and persistent atopic wheezers/asthmatics. Transient wheezers have 
wheeze-related symptoms only during the first 3 years of life, which 
resolve between the ages of 3 and 6. This phenotype is not commonly 
associated with a familial and/or personal atopy or asthma. They have 
reduced lung function diagnosed shortly after birth before any event 
of respiratory illness, which remains decreased until 22 years of age
18). 
Structural or functional changes in airways, such as reduced airway 
resistance or increased compliance, would predispose these subjects 
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factors such as exposure to tobacco smoke. 
The non-atopic wheezer group comprises children whose wheezing 
starts in late infancy or at preschool age and continues beyond 6 
years of age, but has a tendency to disappear pre-adolescence. These 
children have slightly lower lung function compared with non-
wheezing healthy subjects. The principal factor that triggers wheezing 
in this group is acute respiratory infection, and many studies have 
explored the relationship between viral infection and asthma. Stein et 
al. demonstrated, in a longitudinal study, that children who had RSV 
infection during the 1st 3 years of life had a greater risk of having a 
persistent wheeze up to 11 years of age
19). They are more likely to have 
lower lung function but this is not associated with increased risk for 
atopic sensitization. 
The third phenotype, persistent atopic wheezers/asthmatics, is 
composed of the children whose symptoms started during the 1st 
3 years of life and continue during school age and adolescence 
1). 
These children have a familial history of atopy, and early allergic 
sensitization. There is a significant association between an early onset 
of wheezing and disease severity and airway hyper-responsiveness. 
Moreover, early allergic sensitization to aeroallergens has been 
shown to be predictive of persistent wheeze or asthma, airway hyper-
responsiveness, and loss of lung function. 
The Avon Longitudinal Study is a birth cohort study, which 
enrolled 6,265 children from birth and followed them at 6, 18, 30, 
42, 54, 69, and 81 months of age
17). Five phenotypes of wheeze were 
defined by the estimated prevalence of wheezing at each time point: 
transient early wheeze, prolonged early wheeze, intermediate onset 
wheeze, late onset wheeze, and persistent wheeze. Although the 
phenotypes have similarities to those previously reported, there were 
differences in their associations with objective outcomes. Intermediate 
and late onset phenotypes had the strongest asso  ciations with atopy, 
which may present in the critical period during which environmental 
factors such as allergens or viral infections interact with genetic 
predisposition to influence the risk of developing asthma
17). 
Early virus-induced wheezing and childhood asthma
Most children with asthma experience their first episode of 
wheezing during early childhood and those initial insults are usually 
caused by viral respiratory infections. This relationship has been 
suggested in many epidemiological studies, which have shown 
the natural history of asthma and age-related changes in asthma 
phenotypes. The first years of life are a period of rapid growth and 
development in the immune and pulmonary systems and delicate 
regulation of these developmental processes. It is likely that the 
effect of an acute inflammatory response to respiratory infection 
on immature lung structure and function might be asso  ciated with 
the long-term consequences of infection. However, the question of 
whether viral respiratory infection is a causal factor or an indicator 
of a predisposition to asthma is still not resolved. RSV is the most 
common pathogen causing bronchiolitis during infancy and has 
been most widely studied in connection with its relationship with 
subsequent childhood asthma. A previous long-term follow-up 
study has shown that severe RSV bronchiolitis in infancy is an 
independent risk factor for asthma up to age 13
20, 21). Another follow-
up study to age 13, which showed debatable findings, reported 
that RSV bronchiolitis in the first 3 years of life was associated 
with frequent wheezing up to age 11, but no longer at age 13, and 
that this association was not caused by an increased risk of allergic 
sensitization
19). The authors suggest that RSV bronchiolitis itself is not 
a risk factor for the development of atopic asthma. This discrepancy 
might be explained by the fact that the infants enrolled in the 
first study were those with severe RSV bronchiolitis who needed 
hospitalization, while the second one was part of a population-based 
study. These findings are sup  ported by a recent study showing a dose-
response relationship between the severity of infant bronchiolitis 
and early childhood asthma
22). Moreover, a recent study suggested 
that RSV infections severe enough to result in hospitalization are 
an indicator of genetic predisposition, rather than a causative 
factor
23). There has also been a study that demonstrated a significant 
association between RSV-induced wheezing and persistent wheeze 
at 5 years of age, only in children with early atopic sensitization
24). 
An interesting study once proposed a possible genetic link between 
atopy and the severity of RSV infection; a common IL-4 haplotype 
has been shown to be associated with increased IL-4 transcription 
and predisposition to asthma
25). Choi et al. reported that a particular 
IL-4 gene haplo  type, which is associated with increased IL-4 
transcription and predisposition to asthma, is associated with severe 
RSV bronchiolitis in Korean children
25). 
 Collectively, childhood asthma is a complex disease presenting 
heterogeneous wheezing phenotypes, which might be dependent 
upon the interaction of genetic and environmental factors.  
Asthmatic children with airway remodeling
Many children outgrow their preschool wheeze, but others have 
persistent symptoms and go on to develop asthma. Structural 
changes to the airway, airway remodeling, play an important role in 
the pathophysiology of asthma. Thickening of the reticular basement 
membrane (RBM) of the airway epithelium is a characteristic 
finding of remodeling, which is relatively well proven in adults 
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characteristic features of adult asthma in school-aged children
26, 
27). Although such a study is not easily available in young children, 
there has been a series of reports showing that RBM thickening 
and eosinophilic inflammation have not yet started to develop at 
12 months, but have started developing by 30 months of age
28, 29). 
These previous studies suggest that there might be a critical time for 
intervention to modify the natural course of childhood asthma. 
Recent studies have suggested that airway remodeling is a con-
sequence of repeated injury and persistent inflammation of the airway 
epithelium
30). Repeated virus-induced wheezing in early childhood 
has been shown to predict adult asthma
31). We observed previously 
that significantly increased vascular endothelial growth factor 
(VEGF) and plasminogen activator inhibitor (PAI)-1, important 
mediators in the process of structural changes to airways, are present 
in children with recurrent early wheeze
32). More  over, a recent study 
showed significantly increased levels of epidermal growth factor 
(EGF) and amphiregulin during acute asthma exacerbation
33), which 
suggests that airway remodeling processes might progress with every 
acute attack and contribute to the development of chronic asthma. 
Prevention and appropriate management of recurrent asthma attacks 
may be crucial to prevent progressive structural changes in asthmatic 
children.
Conclusion
Asthma is not a single disease entity, but incorporates a number 
of clinical syndromes. There has been a continuous need for the 
identification of clinically relevant phenotypes of asthma, particularly 
during childhood, when many of the major influences on asthma 
development start. Improved classification of asthma phenotypes in 
children is expected to increase our understanding of the etiology and 
natural history of wheezing illnesses in childhood. This will make it 
possible to find novel strategies for primary and secondary prevention 
of disease in specific subgroups and also to develop phenotype-
specific treatment of asthma. 
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